Candace A. Gilbert

1.6k total citations
17 papers, 1.3k citations indexed

About

Candace A. Gilbert is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Candace A. Gilbert has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Candace A. Gilbert's work include Cancer Cells and Metastasis (7 papers), Glioma Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (2 papers). Candace A. Gilbert is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Glioma Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (2 papers). Candace A. Gilbert collaborates with scholars based in United States, India and United Kingdom. Candace A. Gilbert's co-authors include Joyce M. Slingerland, Alonzo H. Ross, Markus D. Siegelin, Dario C. Altieri, Christopher M. Raskett, Richard P. Moser, Marie‐Claire Daou, Diana J. Azzam, Dorraya El‐Ashry and Dekuang Zhao and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Candace A. Gilbert

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Candace A. Gilbert United States 13 765 480 320 155 142 17 1.3k
Christine Cheng United States 16 878 1.1× 220 0.5× 214 0.7× 239 1.5× 78 0.5× 20 1.4k
Jennifer A. Calvo United States 15 1.7k 2.3× 552 1.1× 326 1.0× 137 0.9× 65 0.5× 25 2.3k
Arishya Sharma United States 14 858 1.1× 315 0.7× 215 0.7× 105 0.7× 33 0.2× 15 1.2k
Véronique Gire France 20 1.2k 1.5× 607 1.3× 210 0.7× 67 0.4× 45 0.3× 31 1.8k
Kelly M. McGarvey United States 13 2.1k 2.8× 256 0.5× 334 1.0× 61 0.4× 90 0.6× 15 2.5k
Giacomo Buscemi Italy 20 1.1k 1.4× 533 1.1× 244 0.8× 42 0.3× 65 0.5× 27 1.4k
Johanna Tommiska Finland 25 1.3k 1.7× 590 1.2× 336 1.1× 109 0.7× 48 0.3× 39 1.9k
Marco Da Costa France 10 1.1k 1.4× 343 0.7× 265 0.8× 74 0.5× 334 2.4× 14 2.0k
Hyonchol Jang South Korea 25 1.5k 1.9× 245 0.5× 520 1.6× 54 0.3× 64 0.5× 66 1.9k
Alexander Valent France 18 962 1.3× 659 1.4× 572 1.8× 125 0.8× 46 0.3× 41 1.9k

Countries citing papers authored by Candace A. Gilbert

Since Specialization
Citations

This map shows the geographic impact of Candace A. Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candace A. Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candace A. Gilbert more than expected).

Fields of papers citing papers by Candace A. Gilbert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candace A. Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candace A. Gilbert. The network helps show where Candace A. Gilbert may publish in the future.

Co-authorship network of co-authors of Candace A. Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Candace A. Gilbert. A scholar is included among the top collaborators of Candace A. Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Candace A. Gilbert. Candace A. Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jang, Kibeom, et al.. (2017). VEGFA activates an epigenetic pathway upregulating ovarian cancer‐initiating cells. EMBO Molecular Medicine. 9(3). 304–318. 52 indexed citations
2.
Zhao, Dekuang, Junjun Sun, Candace A. Gilbert, et al.. (2014). VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Oncogene. 34(24). 3107–3119. 219 indexed citations
3.
Azzam, Diana J., Dekuang Zhao, Andy J. Minn, et al.. (2013). Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ‐secretase inhibitor drug responses. EMBO Molecular Medicine. 5(10). 1502–1522. 54 indexed citations
4.
Simpkins, Fiona, Jun Sun, Candace A. Gilbert, et al.. (2012). Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo. Clinical Cancer Research. 18(21). 5911–5923. 54 indexed citations
5.
Gilbert, Candace A. & Joyce M. Slingerland. (2012). Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression. Annual Review of Medicine. 64(1). 45–57. 238 indexed citations
6.
Siegelin, Markus D., Takehiko Dohi, Christopher M. Raskett, et al.. (2011). Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. Journal of Clinical Investigation. 121(4). 1349–1360. 136 indexed citations
8.
Siegelin, Markus D., Janet Plescia, Christopher M. Raskett, et al.. (2010). Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma. Molecular Cancer Therapeutics. 9(6). 1638–1646. 34 indexed citations
9.
Xie, Jenny, Shawna Guillemette, Min Peng, et al.. (2010). An MLH1 Mutation Links BACH1/FANCJ to Colon Cancer, Signaling, and Insight toward Directed Therapy. Cancer Prevention Research. 3(11). 1409–1416. 16 indexed citations
10.
Gilbert, Candace A., Marie‐Claire Daou, Richard P. Moser, & Alonzo H. Ross. (2010). γ-Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence. Cancer Research. 70(17). 6870–6879. 96 indexed citations
11.
Gilbert, Candace A., Li Li, Marie‐Claire Daou, et al.. (2010). Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres. Cancer Letters. 296(2). 168–177. 24 indexed citations
12.
Siegelin, Markus D., Christopher M. Raskett, Candace A. Gilbert, Alonzo H. Ross, & Dario C. Altieri. (2010). Sorafenib exerts anti-glioma activity in vitro and in vivo. Neuroscience Letters. 478(3). 165–170. 65 indexed citations
13.
Gilbert, Candace A., Nicole Hermance, Marie‐Claire Daou, et al.. (2010). Abstract LB-32: Glioma treatment with temozolomide and Notch inhibition suppresses neurosphere formation and xenograft formation. Cancer Research. 70(8_Supplement). LB–32. 1 indexed citations
14.
Gilbert, Candace A. & Alonzo H. Ross. (2009). Cancer stem cells: Cell culture, markers, and targets for new therapies. Journal of Cellular Biochemistry. 108(5). 1031–1038. 144 indexed citations
15.
Fitting, Sylvia, Rosemarie M. Booze, Candace A. Gilbert, & Charles F. Mactutus. (2007). Effects of chronic adult dietary restriction on spatial learning in the aged F344×BN hybrid F1 rat. Physiology & Behavior. 93(3). 560–569. 11 indexed citations
16.
Tate, Jennifer A., Zhongfu Ni, Anne‐Cathrine Scheen, et al.. (2006). Evolution and Expression of Homeologous Loci in Tragopogon miscellus (Asteraceae), a Recent and Reciprocally Formed Allopolyploid. Genetics. 173(3). 1599–1611. 149 indexed citations
17.
Gilbert, Candace A., et al.. (1995). EFFECTS OF ANTISENSE OLIGONUCLEOTIDES TARGETING K-RAS EXPRESSION IN PANCREATIC-CANCER CELL-LINES. International Journal of Oncology. 6(5). 1105–12. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026